Allocation concealment (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Allocation concealment" in English language version.

refsWebsite

Global rank English rank

15nih.gov

4^th place

9doi.org

2^nd place

3worldcat.org

5^th place

2semanticscholar.org

11^th place

8^th place

1mja.com.au

low place

8,161^st place

1archive-it.org

910^th place

593^rd place

1who.int

195^th place

302^nd place

1lshtm.ac.uk

low place

archive-it.org (Global: 910^th place; English: 593^rd place)

wayback.archive-it.org

Schulz KF, Grimes DA (2002). "Allocation concealment in randomised trials: defending against deciphering" (PDF). Lancet. 359 (9306): 614–8. doi:10.1016/S0140-6736(02)07750-4. PMID 11867132. S2CID 12902486. Archived from the original (PDF) on September 11, 2012.

doi.org (Global: 2^nd place; English: 2^nd place)

Forder PM, Gebski VJ, Keech AC (2005). "Allocation concealment and blinding: when ignorance is bliss". Med J Aust. 182 (2): 87–9. doi:10.5694/j.1326-5377.2005.tb06584.x. PMID 15651970. S2CID 202149.
Schulz KF, Grimes DA (2002). "Allocation concealment in randomised trials: defending against deciphering" (PDF). Lancet. 359 (9306): 614–8. doi:10.1016/S0140-6736(02)07750-4. PMID 11867132. S2CID 12902486. Archived from the original (PDF) on September 11, 2012.
Pildal J, Chan AW, Hróbjartsson A, Forfang E, Altman DG, Gøtzsche PC (2005). "Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study". BMJ. 330 (7499): 1049. doi:10.1136/bmj.38414.422650.8F. PMC 557221. PMID 15817527.
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA (2008). "Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study". BMJ. 336 (7644): 601–5. doi:10.1136/bmj.39465.451748.AD. PMC 2267990. PMID 18316340.
Schulz, KF; Chalmers, I; Altman, DG; Grimes, DA; Moher, D; Hayes, RJ (June 2018). "'Allocation concealment': the evolution and adoption of a methodological term" (PDF). Journal of the Royal Society of Medicine. 111 (6): 216–224. doi:10.1177/0141076818776604. PMC 6022887. PMID 29877772.
Furberg, CD; Soliman, EZ (February 2008). "Double-blindness protects scientific validity". Journal of Thrombosis and Haemostasis. 6 (2): 230–1. doi:10.1111/j.1538-7836.2008.02836.x. PMID 18021306.
Torgerson, DJ; Roberts, C (7 August 1999). "Understanding controlled trials. Randomisation methods: concealment". BMJ (Clinical Research Ed.). 319 (7206): 375–6. doi:10.1136/bmj.319.7206.375. ISSN 0959-8138. PMC 1126995. PMID 10435967.
Fava, M.; Johe, K.; Ereshefsky, L.; Gertsik, L. G.; English, B. A.; Bilello, J. A.; Thurmond, L. M.; Johnstone, J.; Dickerson, B. C.; Makris, N.; Hoeppner, B. B.; Flynn, M.; Mischoulon, D.; Kinrys, G.; Freeman, M. P. (2016). "A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients". Molecular Psychiatry. 21 (10): 1372–1380. doi:10.1038/mp.2015.178. ISSN 1476-5578. PMC 5030464. PMID 26643541.
Kennedy, Andrew D. M.; Torgerson, David J.; Campbell, Marion K.; Grant, Adrian M. (December 2017). "Subversion of allocation concealment in a randomised controlled trial: a historical case study". Trials. 18 (1): 204. doi:10.1186/s13063-017-1946-z. ISSN 1745-6215. PMC 5414185. PMID 28464922.

lshtm.ac.uk (Global: low place; English: low place)

researchonline.lshtm.ac.uk

Schulz, KF; Chalmers, I; Altman, DG; Grimes, DA; Moher, D; Hayes, RJ (June 2018). "'Allocation concealment': the evolution and adoption of a methodological term" (PDF). Journal of the Royal Society of Medicine. 111 (6): 216–224. doi:10.1177/0141076818776604. PMC 6022887. PMID 29877772.

mja.com.au (Global: low place; English: 8,161^st place)

Forder PM, Gebski VJ, Keech AC (2005). "Allocation concealment and blinding: when ignorance is bliss". Med J Aust. 182 (2): 87–9. doi:10.5694/j.1326-5377.2005.tb06584.x. PMID 15651970. S2CID 202149.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Forder PM, Gebski VJ, Keech AC (2005). "Allocation concealment and blinding: when ignorance is bliss". Med J Aust. 182 (2): 87–9. doi:10.5694/j.1326-5377.2005.tb06584.x. PMID 15651970. S2CID 202149.
Schulz KF, Grimes DA (2002). "Allocation concealment in randomised trials: defending against deciphering" (PDF). Lancet. 359 (9306): 614–8. doi:10.1016/S0140-6736(02)07750-4. PMID 11867132. S2CID 12902486. Archived from the original (PDF) on September 11, 2012.
Pildal J, Chan AW, Hróbjartsson A, Forfang E, Altman DG, Gøtzsche PC (2005). "Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study". BMJ. 330 (7499): 1049. doi:10.1136/bmj.38414.422650.8F. PMC 557221. PMID 15817527.
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA (2008). "Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study". BMJ. 336 (7644): 601–5. doi:10.1136/bmj.39465.451748.AD. PMC 2267990. PMID 18316340.
Schulz, KF; Chalmers, I; Altman, DG; Grimes, DA; Moher, D; Hayes, RJ (June 2018). "'Allocation concealment': the evolution and adoption of a methodological term" (PDF). Journal of the Royal Society of Medicine. 111 (6): 216–224. doi:10.1177/0141076818776604. PMC 6022887. PMID 29877772.
Furberg, CD; Soliman, EZ (February 2008). "Double-blindness protects scientific validity". Journal of Thrombosis and Haemostasis. 6 (2): 230–1. doi:10.1111/j.1538-7836.2008.02836.x. PMID 18021306.
Torgerson, DJ; Roberts, C (7 August 1999). "Understanding controlled trials. Randomisation methods: concealment". BMJ (Clinical Research Ed.). 319 (7206): 375–6. doi:10.1136/bmj.319.7206.375. ISSN 0959-8138. PMC 1126995. PMID 10435967.
Fava, M.; Johe, K.; Ereshefsky, L.; Gertsik, L. G.; English, B. A.; Bilello, J. A.; Thurmond, L. M.; Johnstone, J.; Dickerson, B. C.; Makris, N.; Hoeppner, B. B.; Flynn, M.; Mischoulon, D.; Kinrys, G.; Freeman, M. P. (2016). "A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients". Molecular Psychiatry. 21 (10): 1372–1380. doi:10.1038/mp.2015.178. ISSN 1476-5578. PMC 5030464. PMID 26643541.
Kennedy, Andrew D. M.; Torgerson, David J.; Campbell, Marion K.; Grant, Adrian M. (December 2017). "Subversion of allocation concealment in a randomised controlled trial: a historical case study". Trials. 18 (1): 204. doi:10.1186/s13063-017-1946-z. ISSN 1745-6215. PMC 5414185. PMID 28464922.

ncbi.nlm.nih.gov

Pildal J, Chan AW, Hróbjartsson A, Forfang E, Altman DG, Gøtzsche PC (2005). "Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study". BMJ. 330 (7499): 1049. doi:10.1136/bmj.38414.422650.8F. PMC 557221. PMID 15817527.
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA (2008). "Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study". BMJ. 336 (7644): 601–5. doi:10.1136/bmj.39465.451748.AD. PMC 2267990. PMID 18316340.
Schulz, KF; Chalmers, I; Altman, DG; Grimes, DA; Moher, D; Hayes, RJ (June 2018). "'Allocation concealment': the evolution and adoption of a methodological term" (PDF). Journal of the Royal Society of Medicine. 111 (6): 216–224. doi:10.1177/0141076818776604. PMC 6022887. PMID 29877772.
Torgerson, DJ; Roberts, C (7 August 1999). "Understanding controlled trials. Randomisation methods: concealment". BMJ (Clinical Research Ed.). 319 (7206): 375–6. doi:10.1136/bmj.319.7206.375. ISSN 0959-8138. PMC 1126995. PMID 10435967.
Fava, M.; Johe, K.; Ereshefsky, L.; Gertsik, L. G.; English, B. A.; Bilello, J. A.; Thurmond, L. M.; Johnstone, J.; Dickerson, B. C.; Makris, N.; Hoeppner, B. B.; Flynn, M.; Mischoulon, D.; Kinrys, G.; Freeman, M. P. (2016). "A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients". Molecular Psychiatry. 21 (10): 1372–1380. doi:10.1038/mp.2015.178. ISSN 1476-5578. PMC 5030464. PMID 26643541.
Kennedy, Andrew D. M.; Torgerson, David J.; Campbell, Marion K.; Grant, Adrian M. (December 2017). "Subversion of allocation concealment in a randomised controlled trial: a historical case study". Trials. 18 (1): 204. doi:10.1186/s13063-017-1946-z. ISSN 1745-6215. PMC 5414185. PMID 28464922.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Forder PM, Gebski VJ, Keech AC (2005). "Allocation concealment and blinding: when ignorance is bliss". Med J Aust. 182 (2): 87–9. doi:10.5694/j.1326-5377.2005.tb06584.x. PMID 15651970. S2CID 202149.
Schulz KF, Grimes DA (2002). "Allocation concealment in randomised trials: defending against deciphering" (PDF). Lancet. 359 (9306): 614–8. doi:10.1016/S0140-6736(02)07750-4. PMID 11867132. S2CID 12902486. Archived from the original (PDF) on September 11, 2012.

who.int (Global: 195^th place; English: 302^nd place)

Schulz KF, Grimes DA (2002). "Allocation concealment in randomised trials: defending against deciphering" (PDF). Lancet. 359 (9306): 614–8. doi:10.1016/S0140-6736(02)07750-4. PMID 11867132. S2CID 12902486. Archived from the original (PDF) on September 11, 2012.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Torgerson, DJ; Roberts, C (7 August 1999). "Understanding controlled trials. Randomisation methods: concealment". BMJ (Clinical Research Ed.). 319 (7206): 375–6. doi:10.1136/bmj.319.7206.375. ISSN 0959-8138. PMC 1126995. PMID 10435967.
Fava, M.; Johe, K.; Ereshefsky, L.; Gertsik, L. G.; English, B. A.; Bilello, J. A.; Thurmond, L. M.; Johnstone, J.; Dickerson, B. C.; Makris, N.; Hoeppner, B. B.; Flynn, M.; Mischoulon, D.; Kinrys, G.; Freeman, M. P. (2016). "A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients". Molecular Psychiatry. 21 (10): 1372–1380. doi:10.1038/mp.2015.178. ISSN 1476-5578. PMC 5030464. PMID 26643541.
Kennedy, Andrew D. M.; Torgerson, David J.; Campbell, Marion K.; Grant, Adrian M. (December 2017). "Subversion of allocation concealment in a randomised controlled trial: a historical case study". Trials. 18 (1): 204. doi:10.1186/s13063-017-1946-z. ISSN 1745-6215. PMC 5414185. PMID 28464922.

Allocation concealment (English Wikipedia)

archive-it.org (Global: 910th place; English: 593rd place)